Agile Therapeutics AGRX reported its Q1 earnings results on Thursday, May 12, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Agile Therapeutics beat estimated earnings by 21.25%, reporting an EPS of $-3.78 versus an estimate of $-4.8.
Revenue was up $1.65 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.05 which was followed by a 12.67% drop in the share price the next day.
Here's a look at Agile Therapeutics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.15 | -0.19 | -0.21 | -0.21 |
| EPS Actual | -0.20 | -0.18 | -0.20 | -0.20 |
| Revenue Estimate | 1.51M | 1.46M | 1.95M | 600.00K |
| Revenue Actual | 1.51M | 1.29M | 1.19M | 116.00K |
To track all earnings releases for Agile Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
